ArticleAnnals of hematology2025

Safe administration of venetoclax-obinutuzumab in a chronic lymphocytic leukemia patient with Brugada syndrome.

Valeria Cardinali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.